Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Feb;10(2):117-28.
doi: 10.1016/j.spinee.2009.09.002.

Dose response and efficacy of spinal manipulation for chronic cervicogenic headache: a pilot randomized controlled trial

Affiliations
Randomized Controlled Trial

Dose response and efficacy of spinal manipulation for chronic cervicogenic headache: a pilot randomized controlled trial

Mitchell Haas et al. Spine J. 2010 Feb.

Abstract

Background context: Systematic reviews of randomized controlled trials suggest that spinal manipulative therapy (SMT) is efficacious for care of cervicogenic headache (CGH). The effect of SMT dose on outcomes has not been studied.

Purpose: To compare the efficacy of two doses of SMT and two doses of light massage (LM) for CGH.

Patient sample: Eighty patients with chronic CGH.

Main outcome measures: Modified Von Korff pain and disability scales for CGH and neck pain (minimum clinically important difference=10 on 100-point scale), number of headaches in the last 4 weeks, and medication use. Data were collected every 4 weeks for 24 weeks. The primary outcome was the CGH pain scale.

Methods: Participants were randomized to either 8 or 16 treatment sessions with either SMT or a minimal LM control. Patients were treated once or twice per week for 8 weeks. Adjusted mean differences (AMD) between groups were computed using generalized estimating equations for the longitudinal outcomes over all follow-up time points (profile) and using regression modeling for individual time points with baseline characteristics as covariates and with imputed missing data.

Results: For the CGH pain scale, comparisons of 8 and 16 treatment sessions yielded small dose effects: |AMD|</=5.6. There was an advantage for SMT over the control: AMD=-8.1 (95% confidence interval=-13.3 to -2.8) for the profile, -10.3 (-18.5 to -2.1) at 12 weeks, and -9.8 (-18.7 to -1.0) at 24 weeks. For the higher dose patients, the advantage was greater: AMD=-11.9 (-19.3 to -4.6) for the profile, -14.2 (-25.8 to -2.6) at 12 weeks, and -14.4 (-26.9 to -2.0) at 24 weeks. Patients receiving SMT were also more likely to achieve a 50% improvement in pain scale: adjusted odds ratio=3.6 (1.6 to 8.1) for the profile, 3.1 (0.9 to 9.8) at 12 weeks, and 3.1 (0.9 to 10.3) at 24 weeks. Secondary outcomes showed similar trends favoring SMT. For SMT patients, the mean number of CGH was reduced by half.

Conclusions: Clinically important differences between SMT and a control intervention were observed favoring SMT. Dose effects tended to be small.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Patient flow diagram. All patients were assigned 16 visits where they received spinal manipulative therapy (SMT), light massage (LM), or attention control physical exam (att). Adherence to study visits and compliance with follow-up are identified.
Fig 2
Fig 2
Adjusted mean cervicogenic headache pain. Predicted follow-up means were computed using simultaneous regression analysis adjusted for the baseline covariates. The analysis assumes all groups start at the grand baseline mean pain (shown at week 0).
Fig3
Fig3
Adjusted mean number of cervicogenic headaches. Predicted follow-up means were computed using simultaneous regression analysis adjusted for the baseline covariates. The analysis assumes all groups start at the grand baseline mean pain (shown at week 0).

Comment in

References

    1. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidmiology of headache in a general population-a prevalence study. J Clin Epidemiol. 1991;44:1147–57. - PubMed
    1. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache. 1999;39:190–6. - PubMed
    1. Scher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998;38:497–506. - PubMed
    1. Nilsson-Grunnet N. Epidemiology of Headache. Euro J Chiro. 2002;49:33–5.
    1. Solomon GD, Skobieranda FG, Gragg LA. Quality of life and well-being of headache patients: measurement by the Medical outcomes study instrument. Headache. 1993:351–8. - PubMed

Publication types